Venmax Drugs and Pharmaceuticals Limited has informed the exchange about the update in respect of Scheme of Amalgamation of Hatri Pharma Private Limited (Amalgamating Company) with Venmax Drugs and Pharmaceuticals Limited ( Amalgamated Company).
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 08 2026
Filed with BSE · · 20 pages · English
Summary by 6ix AI
This filing is a disclosure regarding a scheme of amalgamation involving Venmax Drugs & Pharmaceuticals Ltd. and Hatri Pharma Private Limited, as ordered by the National Company Law Tribunal. The tribunal has directed Venmax to convene a meeting of its equity shareholders to discuss the amalgamation scheme.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 01 2026
- Reg. 34 (1) Annual Report.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 31 2026
- Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 24 2026
Later from Venmax Drugs & Pharmaceuticals
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 25 2026
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2026
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals